Literature DB >> 19066418

Prolonged pretreatment with carvedilol prevents 3-nitropropionic acid-induced behavioral alterations and oxidative stress in rats.

Puneet Kumar1, Anil Kumar.   

Abstract

3-nitropropionic acid (3-NP)-induced neurotoxicity causes a cellular energy deficit and oxidative stress via an irreversible inhibition of the mitochondrial enzyme succinate dehydrogenase (SDH). Systemic administration of 3-NP causes motor and cognitive deficits, particularly those associated with excessive free radical generation. Recently, carvedilol has been implicated as a neuroprotectant in the treatment of various neurological disorders. The present study was designed to investigate the neuroprotective effects of carvedilol against 3-NP-induced cognitive impairment and oxidative damage in rats. Intraperitoneal administration of 3-NP (20 mg/kg for 4 days) caused significant body weight reduction, impaired motor function (locomotor activity, movement pattern), induced vacuous chewing movements, led to poor retention of memory in the Morris water maze, and elevated plus maze task paradigms. Chronic treatment with carvedilol (1 and 2 mg/kg, po), once daily for a period of 8 days beginning 4 days before 3-NP administration, significantly reversed 3-NP-induced motor impairment and cognitive deficits. However, carvedilol (1 and 2 mg/kg, po) treatment significantly attenuated oxidative damage (reduced lipid peroxidation and nitrite levels, and restored depleted reduced glutathione and succinate dehydrogenase enzyme activity) in the rat brain. The results of the present study suggest that carvedilol has a neuroprotective effect against 3-NP-induced behavioral alterations and oxidative damage.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19066418

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  9 in total

1.  Neuroprotective effect of carvedilol and melatonin on 3-nitropropionic acid-induced neurotoxicity in neuroblastoma.

Authors:  I Tasset; C Espínola; F J Medina; M Feijóo; C Ruiz; E Moreno; M M Gómez; J A Collado; C Muñoz; J Muntané; P Montilla; I Túnez
Journal:  J Physiol Biochem       Date:  2009-09       Impact factor: 4.158

2.  Role of LOX/COX pathways in 3-nitropropionic acid-induced Huntington's disease-like symptoms in rats: protective effect of licofelone.

Authors:  Puneet Kumar; Harikesh Kalonia; Anil Kumar
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

3.  Antioxidant and antiapoptotic actions of selegiline protect against 3-NP-induced neurotoxicity in rats.

Authors:  Sara A Wahdan; Mariane G Tadros; Amani E Khalifa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-06-23       Impact factor: 3.000

4.  Berberine Ameliorate Haloperidol and 3-Nitropropionic Acid-Induced Neurotoxicity in Rats.

Authors:  Abdul Kadir; Jasdeep Singh; Vikrant Rahi; Puneet Kumar
Journal:  Neurochem Res       Date:  2022-07-25       Impact factor: 4.414

5.  Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro.

Authors:  Qingqing Yin; Jian Chen; Shizhan Ma; Chuanfang Dong; Yue Zhang; Xunyao Hou; Shangbin Li; Bin Liu
Journal:  J Inflamm Res       Date:  2020-09-15

6.  Protective Effects of Vasodilatory Βeta-Blockers Carvedilol and Nebivolol against Glycerol Model of Rhabdomyolysis-Induced Acute Renal Failure in Rats.

Authors:  Ahmed Atwa; Rehab Hegazy; Nermeen Shaffie; Neamat Yassin; Sanaa Kenawy
Journal:  Open Access Maced J Med Sci       Date:  2016-08-01

Review 7.  Protective Effect of Antioxidants on Neuronal Dysfunction and Plasticity in Huntington's Disease.

Authors:  Thirunavukkarasu Velusamy; Archana S Panneerselvam; Meera Purushottam; Muthuswamy Anusuyadevi; Pramod Kumar Pal; Sanjeev Jain; Musthafa Mohamed Essa; Gilles J Guillemin; Mahesh Kandasamy
Journal:  Oxid Med Cell Longev       Date:  2017-01-12       Impact factor: 6.543

Review 8.  Fatty Acids: An Insight into the Pathogenesis of Neurodegenerative Diseases and Therapeutic Potential.

Authors:  Diego Julián Vesga-Jiménez; Cynthia Martin; George E Barreto; Andrés Felipe Aristizábal-Pachón; Andrés Pinzón; Janneth González
Journal:  Int J Mol Sci       Date:  2022-02-25       Impact factor: 5.923

9.  Pioglitazone improves cognitive function via increasing insulin sensitivity and strengthening antioxidant defense system in fructose-drinking insulin resistance rats.

Authors:  Qing-Qing Yin; Jin-Jing Pei; Song Xu; Ding-Zhen Luo; Si-Qing Dong; Meng-Han Sun; Li You; Zhi-Jian Sun; Xue-Ping Liu
Journal:  PLoS One       Date:  2013-03-20       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.